Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection

BACKGROUND: Concerns regarding potential toxicity and drug-drug interactions during long-term treatment with three-drug active antiretroviral therapy (ART) regimens have been attracting increasing attention. We aimed to evaluate the efficacy and safety of dolutegravir (DTG) plus lamivudine (3TC) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lisi, Li, Chunna, Chen, Ping, Luo, Xiaoqing, Zheng, Xinchun, Zhou, Lanlan, Zhou, Yi, Xia, Jinyu, Hong, Zhongsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725510/
https://www.ncbi.nlm.nih.gov/pubmed/34983415
http://dx.doi.org/10.1186/s12879-021-06991-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8725510/
https://www.ncbi.nlm.nih.gov/pubmed/34983415
http://dx.doi.org/10.1186/s12879-021-06991-y

Ejemplares similares